Boston Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
354 Merrimack St Ste 4, Lawrence, Massac...Phone Number
(603) 935-9799Website
www.bostonti.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Boston Therapeutics
Boston Therapeutics is a biotechnology company and innovator in design, development and commercialization of compounds to manage diabetes and diabetes related complications. The company is headquartered in Lawrence, Massachusetts.Explore more
Boston Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Boston Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Boston Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Boston Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Boston Therapeutics
Product Launch: Get notified when Boston Therapeutics launches new products
Funding: Get notified immidiatlly once Boston Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Boston Therapeutics recently announced quarterly report
Check if Boston Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Boston Therapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Boston Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Boston Therapeutics
Compare insights from companies similar to Boston Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Boston Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Boston Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Boston Therapeutics.
Boston Therapeutics financials insights
Gather financial insights about Boston Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Stock Offering
$20M
2016
Debt
$1.3M
Debt
$1.6M
Boston Therapeutics Tech Stack
A closer look at the technologies used by Boston Therapeutics
Boston Therapeutics News & Media
Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer
SAN LEANDRO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care (POC) diagnostics, today announced the appointment of Christopher R. Hetterly as Chief Financial Officer (CFO).Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.
SAN LEANDRO, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostics, today announced that it has entered into an exclusive distribution agreement with Woodley Equipment Company, Ltd. (“Woodley”), a global veterinary distributor. Under the agreement, Woodley will work with Nanomix to develop species specific ranges for the S1 critical infection panel and distributeNanomix Enters into Distribution Agreement for the eLab System and Future New Products with IPS Genomix s.a.l. in the Middle East
SAN LEANDRO, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that it has entered into a distribution agreement with IPS Genomix s.a.l. (“IPS”), a medical diagnostics distributor with offices in Beirut, Lebanon and Dubai, UAE. IPS will market and distribute the Nanōmix eLab® system, including the Nanōmix S1 Panel assay and future, new test producNanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies
Point-of-care technology to offer patients a timely, highly accurate status of their protection against COVID-19 Point-of-care technology to offer patients a timely, highly accurate status of their protection against COVID-19
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Boston Therapeutics
Sign Up For FreeTo access detailed company insights
Boston Therapeutics is a biotechnology company and innovator in design, development and commercialization of compounds to manage diabetes and diabetes related complications. The company is headquartered in Lawrence, Massachusetts.... Read More
